Publication:
Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study

Issued Date

2019-10-01

Resource Type

Article

ISSN

14681293
14642662

DOI

10.1111/hiv.12779

Other identifier(s)

2-s2.0-85069869768

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

HIV Medicine. Vol.20, No.9 (2019), 615-623

Suggested Citation

R. Bijker, N. Kumarasamy, S. Kiertiburanakul, S. Pujari, L. Penh Sun, O. T. Ng, M. P. Lee, J. Y. Choi, K. V. Nguyen, Y. J. Chan, T. P. Merati, C. D. Do, J. Ross, M. Law, P. S. Ly, V. Khol, P. C.K. Li, W. Lam, Y. T. Chan, S. Saghayam, C. Ezhilarasi, K. Joshi, S. Gaikwad, A. Chitalikar, D. N. Wirawan, F. Yuliana, P. L. Lim, L. S. Lee, Z. Ferdous, S. Na, J. M. Kim, W. W. Wong, W. W. Ku, P. C. Wu, A. V. Ngo, L. T. Nguyen, H. V. Bui, D. T.H. Nguyen, D. T. Nguyen, A. H. Sohn, J. L. Ross, B. Petersen, A. Jiamsakul, D. Rupasinghe, M. G. Law Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study. HIV Medicine. Vol.20, No.9 (2019), 615-623. doi:10.1111/hiv.12779 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51404

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study

Author(s)

R. Bijker
 N. Kumarasamy
 S. Kiertiburanakul
 S. Pujari
 L. Penh Sun
 O. T. Ng
 M. P. Lee
 J. Y. Choi
 K. V. Nguyen
 Y. J. Chan
 T. P. Merati
 C. D. Do
 J. Ross
 M. Law
 P. S. Ly
 V. Khol
 P. C.K. Li
 W. Lam
 Y. T. Chan
 S. Saghayam
 C. Ezhilarasi
 K. Joshi
 S. Gaikwad
 A. Chitalikar
 D. N. Wirawan
 F. Yuliana
 P. L. Lim
 L. S. Lee
 Z. Ferdous
 S. Na
 J. M. Kim
 W. W. Wong
 W. W. Ku
 P. C. Wu
 A. V. Ngo
 L. T. Nguyen
 H. V. Bui
 D. T.H. Nguyen
 D. T. Nguyen
 A. H. Sohn
 J. L. Ross
 B. Petersen
 A. Jiamsakul
 D. Rupasinghe
 M. G. Law

Other Contributor(s)

The Voluntary Health Services, Chennai
 Bach Mai Hospital
 Universitas Udayana
 Kirby Institute
 Yonsei University College of Medicine
 Faculty of Medicine, Ramathibodi Hospital, Mahidol University
 Queen Elizabeth Hospital Hong Kong
 Veterans General Hospital-Taipei
 Tan Tock Seng Hospital
 University of Health Sciences
 National Hospital for Tropical Diseases
 Foundation for AIDS Research
 Institute of Infectious Diseases

Abstract

© 2019 British HIV Association Objectives: Diabetes is a growing cause of morbidity and mortality in people living with HIV (PLHIV) receiving antiretroviral therapy (ART). We investigated the association between fasting plasma glucose (FPG) levels and mortality, and factors associated with FPG monitoring rates in Asia. Methods: Patients from the Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia) HIV Observational Database Low Intensity Transfer (TAHOD-LITE) cohort were included in the present study if they had initiated ART. Competing risk and Poisson regression were used to analyse the association between FPG and mortality, and assess risk factors for FPG monitoring rates, respectively. FPG was categorized as diabetes (FPG ≥ 7.0 mmol/L), prediabetes (FPG 5.6–6.9 mmol/L) and normal FPG (FPG ' 5.6 mmol/L). Results: In total, 33 232 patients were included in the analysis. Throughout follow-up, 59% had no FPG test available. The incidence rate for diabetes was 13.7 per 1000 person-years in the 4649 patients with normal FPG at ART initiation. Prediabetes [sub-hazard ratio (sHR) 1.32; 95% confidence interval (CI) 1.07–1.64] and diabetes (sHR 1.90; 95% CI 1.52–2.38) were associated with mortality compared to those with normal FPG. FPG monitoring increased from 0.34 to 0.78 tests per person-year from 2012 to 2016 (P ' 0.001). Male sex [incidence rate ratio (IRR) 1.08; 95% CI 1.03–1.12], age ' 50 years (IRR 1.14; 95% CI 1.09–1.19) compared to ≤ 40 years, and CD4 count ≥ 500 cells/μL (IRR 1.04; 95% CI 1.00–1.09) compared to ' 200 cells/μL were associated with increased FPG monitoring. Conclusions: Diabetes and prediabetes were associated with mortality. FPG monitoring increased over time; however, less than half of our cohort had been tested. Greater resources should be allocated to FPG monitoring for early diabetic treatment and intervention and to optimize survival.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/51404

Collections

Scopus 2019